{"id":"https://openalex.org/W3012015620","doi":"https://doi.org/10.1371/journal.pone.0229850","title":"Brain Shuttle Neprilysin reduces central Amyloid-\u03b2 levels","display_name":"Brain Shuttle Neprilysin reduces central Amyloid-\u03b2 levels","publication_year":2020,"publication_date":"2020-03-10","ids":{"openalex":"https://openalex.org/W3012015620","doi":"https://doi.org/10.1371/journal.pone.0229850","mag":"3012015620","pmid":"https://pubmed.ncbi.nlm.nih.gov/32155191","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7064168"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0229850","doi":"https://doi.org/10.1371/journal.pone.0229850","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0229850","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0229850&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0229850&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113897984","display_name":"Christopher R. Campos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Christopher R. Campos","raw_affiliation_strings":["Neuroscience Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091122196","display_name":"Alicia M. Kemble","orcid":"https://orcid.org/0000-0002-8503-4474","observed_orcids":["https://orcid.org/0000-0002-8503-4474"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Alicia M. Kemble","raw_affiliation_strings":["Neuroscience Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055050909","display_name":"Jens Niewoehner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jens Niewoehner","raw_affiliation_strings":["Large Molecule Research, Roche Pharma Research and Early Development, Roche Innovation Center Munich, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Large Molecule Research, Roche Pharma Research and Early Development, Roche Innovation Center Munich, Munich, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109083013","display_name":"Per\u2010Ola Freskg\u00e5rd","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Per-Ola Freskg\u00e5rd","raw_affiliation_strings":["Neuroscience Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023963566","display_name":"Eduard Urich","orcid":"https://orcid.org/0000-0003-0238-5517","observed_orcids":["https://orcid.org/0000-0003-0238-5517"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Eduard Urich","raw_affiliation_strings":["Neuroscience Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0003-0238-5517","affiliations":[{"raw_affiliation_string":"Neuroscience Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5023963566"],"corresponding_institution_ids":["https://openalex.org/I118019719"],"apc_list":{"value":1695,"currency":"USD","value_usd":1695},"apc_paid":{"value":1695,"currency":"USD","value_usd":1695},"fwci":2.1373,"has_fulltext":true,"cited_by_count":48,"citation_normalized_percentile":{"value":0.87187881,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"15","issue":"3","first_page":"e0229850","last_page":"e0229850"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neprilysin","display_name":"neprilysin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.8059999942779541},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9879999756813049},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.828000009059906},{"id":"https://openalex.org/keywords/cerebrospinal-fluid","display_name":"cerebrospinal fluid","score":0.9559999704360962},{"id":"https://openalex.org/keywords/transferrin-receptor","display_name":"transferrin receptor","score":0.8330000042915344},{"id":"https://openalex.org/keywords/amyloid-beta-degradation","display_name":"amyloid beta degradation","score":0.7760000228881836},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8840000033378601},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.7699999809265137},{"id":"https://openalex.org/keywords/repeated-dosing","display_name":"repeated dosing","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C104826730","wikidata":"https://www.wikidata.org/wiki/Q414232","display_name":"Neprilysin","level":3,"score":0.9361674785614014},{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.6023003458976746},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.5358871817588806},{"id":"https://openalex.org/C196822366","wikidata":"https://www.wikidata.org/wiki/Q270524","display_name":"Parenchyma","level":2,"score":0.5080983638763428},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4862626791000366},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4723469018936157},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4693354666233063},{"id":"https://openalex.org/C32264632","wikidata":"https://www.wikidata.org/wiki/Q1134983","display_name":"Transferrin receptor","level":3,"score":0.44828900694847107},{"id":"https://openalex.org/C16613235","wikidata":"https://www.wikidata.org/wiki/Q285982","display_name":"Endogeny","level":2,"score":0.44162410497665405},{"id":"https://openalex.org/C2777790613","wikidata":"https://www.wikidata.org/wiki/Q191562","display_name":"Cerebral amyloid angiopathy","level":4,"score":0.4176228642463684},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.3467227518558502},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3367801606655121},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30410367250442505},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.288337767124176},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2424558699131012},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23603644967079163},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.18780994415283203},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.09508717060089111},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015260","descriptor_name":"Neprilysin","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D015260","descriptor_name":"Neprilysin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015260","descriptor_name":"Neprilysin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1371/journal.pone.0229850","doi":"https://doi.org/10.1371/journal.pone.0229850","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0229850","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0229850&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7064168","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7064168","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:32155191","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32155191","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:aa89271f13884ee2b314a47af6c49151","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/aa89271f13884ee2b314a47af6c49151","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 15, Iss 3, p e0229850 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0229850","doi":"https://doi.org/10.1371/journal.pone.0229850","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0229850","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0229850&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3012015620.pdf","grobid_xml":"https://content.openalex.org/works/W3012015620.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1605885548","https://openalex.org/W1994344429","https://openalex.org/W1994372862","https://openalex.org/W1998208719","https://openalex.org/W2001498167","https://openalex.org/W2025061302","https://openalex.org/W2028403300","https://openalex.org/W2038003980","https://openalex.org/W2039275066","https://openalex.org/W2048428129","https://openalex.org/W2052825194","https://openalex.org/W2054542987","https://openalex.org/W2114160207","https://openalex.org/W2125414571","https://openalex.org/W2160428452","https://openalex.org/W2254055625","https://openalex.org/W2782455960","https://openalex.org/W2807149247","https://openalex.org/W2807578036","https://openalex.org/W2907547898","https://openalex.org/W2909242954","https://openalex.org/W3140206294"],"related_works":["https://openalex.org/W1997397907","https://openalex.org/W4311289597","https://openalex.org/W1975088357","https://openalex.org/W2129337589","https://openalex.org/W2125414571","https://openalex.org/W2073991180","https://openalex.org/W2089311308","https://openalex.org/W1973995266","https://openalex.org/W2152289099","https://openalex.org/W4235666784"],"abstract_inverted_index":{"Reducing":[0],"Amyloid":[1],"\u03b2":[2],"(A\u03b2)":[3],"in":[4,81,89,104,108,137,170],"the":[5,13,29,37,41,57,78,82,85,109,117,150,154,162],"brain":[6,38,140],"is":[7],"of":[8,28,34,61,130,156],"fundamental":[9],"importance":[10],"for":[11,15,51],"advancing":[12],"therapeutics":[14],"Alzheimer`s":[16],"disease.":[17],"The":[18,70],"endogenous":[19],"metallopeptidase":[20],"neprilysin":[21],"(NEP)":[22],"has":[23],"been":[24],"identified":[25],"as":[26],"one":[27],"key":[30],"A\u03b2-degrading":[31],"enzymes.":[32],"Delivery":[33],"NEP":[35,62,97,118],"to":[36,63,76,125,165],"by":[39,133],"utilizing":[40],"Brain":[42],"Shuttle":[43],"(BS)":[44],"transport":[45,155],"system":[46],"offers":[47],"a":[48,126,146],"promising":[49],"approach":[50],"clearing":[52],"central":[53],"A\u03b2.":[54],"We":[55],"fused":[56],"extracellular":[58],"catalytic":[59],"domain":[60],"an":[64,120,157],"active":[65,121],"or":[66],"inactive":[67],"BS":[68,122,147],"module.":[69],"two":[71],"BS-NEP":[72],"constructs":[73],"were":[74],"used":[75],"investigate":[77],"pharmacokinetic/pharmacodynamics":[79],"relationships":[80],"blood":[83,105],"and":[84,91,139,173],"cerebrospinal":[86],"fluid":[87],"(CSF)":[88],"dose-response":[90],"multiple":[92],"dosing.":[93],"As":[94],"previously":[95],"shown,":[96],"was":[98],"highly":[99],"effective":[100],"at":[101],"degrading":[102,159],"A\u03b2":[103,135,158,168],"but":[106],"not":[107],"CSF":[110,128,138,172],"compartment":[111],"after":[112],"systemic":[113],"administration.":[114],"In":[115],"contrast,":[116],"with":[119],"module":[123,148],"led":[124],"significant":[127],"exposure":[129],"BS-NEP,":[131],"followed":[132],"substantial":[134],"reduction":[136],"parenchyma.":[141],"Our":[142],"data":[143],"show":[144],"that":[145],"against":[149],"transferrin":[151],"receptor":[152],"facilitates":[153],"enzyme":[160],"across":[161],"blood-brain":[163],"barriers":[164],"efficiently":[166],"reduce":[167],"levels":[169],"both":[171],"brain.":[174]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":18},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-03-23T00:00:00"}